New screening methods for chemicals with hormonal activities using interaction of nuclear hormone receptor with coactivator

Toxicology and Applied Pharmacology

Volumn 154, Issue 1, 1999, Pages 76-83

  Nishikawa, Jun Ichi ^a   Saito, Koichi ^a,b   Goto, Jun ^a   Dakeyama, Fumi ^a   Matsuo, Masatoshi ^a,b   Nishihara, Tsutomu ^a  

^a OSAKA UNIVERSITY   (Japan)

^b SUMITOMO CHEMICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN DERIVATIVE; HORMONE RECEPTOR;

ARTICLE; CELL DIFFERENTIATION; DRUG RECEPTOR BINDING; EMBRYO DEVELOPMENT; ENDOCRINE DISEASE; ENDOCRINE FUNCTION; ESTROGEN ACTIVITY; HORMONE ACTION; NONHUMAN; REPRODUCTIVE TOXICITY; SCREENING TEST; TRANSCRIPTION INITIATION;

EID: 0032894856     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1998.8557     Document Type: Article

References (26)

1. Arnold S. F., Robinson M. K., Notides A. C., Guillette L. J., McLachlan J. A. A yeast estrogen screen for examining the relative exposure of cells to natural and xenoestrogens. Environ. Health Perspect. 104:1996;544-548.
2. Barettino D., Vivanco Ruiz M. M., Stunnenberg H. G. Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor. EMBO J. 13:1994;3039-3049.
3. Cavaillés V., Dauvois S., L'Horset F., Lopez G., Hoare S., Kushner P. J., Parker M. G. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO, J. 14:1995;3741-3751.
4. Chen H., Lin R. J., Schiltz R. L., Chakravarti D., Nash A., Nagy L., Privalsky M. L., Nakatani Y., Evans R. M. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell. 90:1997;569-580.
5. Chrivia J. C., Kwok R. P., Lamb N., Hagiwara M., Montminy M. R., Goodman R. H. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature. 365:1993;855-859.
6. Colborn T., Dumanoski D., Myers J. P. Our Stolen Future. 1996;Dutton, New York.
7. Danielian P. S., White R., Lees J. A., Parker M. G. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J. 11:1992;1025-1033.
8. Durand B., Sanders M., Gaudon C., Roy B., Losson R., Chambon P. Activation function 2 (AF-2) of retinoic acid receptor and 9-cis. EMBO J. 13:1994;5370-5382.
9. Eckner R., Ewen M. E., Newsome D., Gerdes M., DeCaprio J. A., Lawrence J. B., Livingston D. M. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 8:1994;869-884.
10. Gaido K. W., Leonard L. S., Lovell S., Gould J. C., Babaî D., Portier C. J., McDonnell D. P. Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. Toxicol. Appl. Pharmacol. 143:1997;205-212.
11. Herry D. M., Kalkhoven E., Hoare S., Parker M. G. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature. 387:1997;733-736.
12. Hong H., Kohli K., Trivedi A., Johnson D. L., Stallcup M. R. GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. Proc. Natl. Acad. Sci. USA. 93:1996;4948-4952.
13. Horwitz K. B., Jackson T. A., Bain D. L., Richer J. K., Takimoto G. S., Tung L. Nuclear receptor coactivators and corepressors. Mol. Endocrinol. 10:1996;1167-1177.
14. Kamei Y., Xu L., Heinzel T., Torchia J., Kurokawa R., Gloss B., Lin S.-C., Heyman R. A., Rose D. W., Glass C. K., Rosenfeld M. G. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell. 85:1996;403-414.
15. Koike S., Sakai M., Muramatsu M. Molecular cloning and characteriztion of rat estrogen receptor. Nucleic Acid Res. 15:1987;2499-2513.
16. Le Douarin B., Zechel C., Garnier J-M., Lutz Y., Tora L., Pierrat B., Heery D., Gronemeyer H., Chambon P., Losson R. TheN. EMBO J. 14:1995;2020-2033.
17. Lee J. W., Ryan F., Swaffield J. C., Johnston S. A., Moore D. D. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature. 374:1995;91-94.
18. Mangelsdorf D. J., Evans R. M. The RXR hetrodimers and orphan receptors. Cell. 83:1995;841-850.
19. Mangelsdorf D. J., Thummel C., Beato M., Herrlich P., Schütz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R. M. The nuclear receptor superfamily: The second decade. Cell. 83:1995;835-839.
20. Onate S. A., Tsai S. Y., Tsai M. -J., O'Malley B. W. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science (Washington, D.C.). 270:1995;1354-1357.
21. Renaud J.-P., Rochel N., Ruff M., Vivat V., Chambon P., Gronemeyer H., Moras D. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans. Nature. 378:1995;681-689.
22. Torchia J., Rose D. W., Inostroza J., Kamei Y., Westin S., Glass C. K., Rosenfeld M. G. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature. 387:1997;677-684.
23. Tsai M. -J., O'Malley B. W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63:1994;451-486.
24. Voegel J. J., Heine M. J. S., Zechel C., Chambon P., Gronemeyer H. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J. 15:1996;3667-3675.
25. vom Baur E., Zechel C., Heery D., Heine M. J. S., Garnier J. M., Vivat V., Le Douarin B., Gronemeyer H., Chambon P., Losson R. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and putative transcriptional intermediary factors, mSUG1 and TIF1. EMBO J. 15:1996;110-124.
26. Wagner R. L., Apriletti J. W., McGrath M. E., West B. L., Baxter J. D., Fletterick R. J. A structural role for hormone in the thyroid hormone receptor. Nature. 378:1995;690-697.